US Patent 11247987 Inhibiting ubiquitin specific peptidase 30
Patent 11247987 was granted and assigned to FORMA Therapeutics on February, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 5, 2018
Date of Patent
February 15, 2022
Patent Applicant
Patent Application Number
16753439
Patent Citations Received
Patent Inventor Names
Stephanos Ioannidis
0
Steven Mischke
0
Alexandre Joseph Buckmelter
0
Bingsong Han
0
Cuixian Liu
0
David James Richard
0
Justin Caravella
0
Matthew W. Martin
0
Scot Mente
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11247987 Inhibiting ubiquitin specific peptidase 30
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.